Over-expression of CDH22 is associated with tumor progression in colorectal cancer

Tumor Biology

Volumn 30, Issue 3, 2009, Pages 130-140

  Zhou, Jun ^a   Li, Jianming ^a   Chen, Juanzhi ^a   Liu, Yuhong ^a   Gao, Weizhe ^a   Ding, Yanqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

CDH22; Colorectal cancer; Progression

Indexed keywords

CADHERIN; CADHERIN CDH 22; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 67449164213     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225242     Document Type: Article

References (22)

1. Friedlich MS, Stern HS: Primary prevention: what can you tell your patient? Surg Oncol Clin N Am 2000;9:655-660; discussion 661-1653
2. Rosen M, Chan L, Beart RW Jr, Vukasin P, Anthone G: Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998;41:1116-1126.
3. Wheelock MJ, Johnson KR: Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003;19:207-235.
4. Takeichi M: Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-811.
5. Christofori G, Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999;24:73-76. (Pubitemid 29346577)
6. Cavallaro U, Christofori G: Cell adhesion and signalling by cadherins and IG-CAMS in cancer. Nat Rev Cancer 2004;4:118-132. (Pubitemid 38198740)
7. Christofori G: Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 2003;22:2318-2323.
8. Sugimoto K, Honda S, Yamamoto T, Ueki T, Monden M, Kaji A, Matsumoto K, Nakamura T: Molecular cloning and characterization of a newly identified member of the cadherin family, PB-cadherin. J Biol Chem 1996;271:11548-11556. (Pubitemid 26156000)
9. Wu J, Jester WF Jr, Laslett AL, Meinhardt A, Orth JM: Expression of a novel factor, short-type PB-cadherin, in Sertoli cells and spermatogenic stem cells of the neonatal rat testis. J Endocrinol 2003;176:381-391. (Pubitemid 36410421)
10. Wu J, Jester WF Jr, Orth JM: Short-type PB-cadherin promotes survival of gonocytes and activates JAK-STAT signalling. Dev Biol 2005;284:437-450. (Pubitemid 41188147)
11. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993;85:200-206. (Pubitemid 23046895)
12. Rashidi B, Gamagami R, Sasson A, Sun FX, Geller J, Moossa AR, Hoffman RM: An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. Clin Cancer Res 2000;6:2556-2561. (Pubitemid 30399228)
13. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-790. (Pubitemid 30679693)
14. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB: N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 2007;67:3106-3116. (Pubitemid 46724847)
15. Shimazui T, Yoshikawa K, Uemura H, Hirao Y, Saga S, Akaza H: The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma. Cancer 2004;101:963-968. (Pubitemid 39100429)
16. Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC: P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 2005;11:5869-5877. (Pubitemid 41170315)
17. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-644.
18. Cavallaro U: N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 2004;5:1274-1278.
19. Wu J, Zhang Y, Tian GG, Zou K, Lee CM, Yu Q, Yuan Z: Short-type PB-cadherin promotes self-renewal of spermatogonial stem sells via multiple signaling pathways. Cell Signal 2008;20:1052-1060.
20. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS: Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005;171:1023-1034. (Pubitemid 41815834)
21. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA: A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007;13:7003-7011. (Pubitemid 350276881)
22. Hazan RB, Qiao R, Keren R, Badano I, Suyama K: Cadherin switch in tumor progression. Ann NY Acad Sci 2004;1014:155-163.